The first NOAC with
a reversal agent
a reversal agent
YOUR FORESIGHT.
HIS FUTURE.
Dabigatran etexilate (Pradaxa®) is proven to be safe and effective to lower the risk of stroke and gives you the assurance of reversibility with Idarucizumab (Praxbind®) in emergency situations.
NOAC Safety in Clinical Practice: Evidence From The Real World
Document ID: MPR-PH-100020
01/06/2018
Author: Prof. Gregory Lip
Real world evidence gives us the opportunity to see how medical intervention compares to treatments other than those studied in the clinical trials to look at different outcomes and different settings and to see how the treatment works in a broader patient population including patients of different ages, race, comorbidities, co-medication and levels of adherence
123,000
Views
100k 340
Related content
07:09
Production date: May 2019